ArticleDrug and alcohol dependence2026
Association between ENDS device and liquid characteristics and cigarette smoking, quitting and smoking reduction behaviors among U.S. adults who frequently use ENDS.
Article in Drug and alcohol dependence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introductionElectronic nicotine delivery systems (ENDS) may support cigarette cessation. We examine whether ENDS device and liquid characteristics are associated with cigarette smoking cessation and reduction.
methodsData are from U.S. adults (21 +) who used ENDS ≥ 5 days/week of a longitudinal study. Participants included 202 adults who completed Wave 3 (September-November 2021) and 4 (July-September 2022) and smoked in Wave 3; and 196 adults who completed Wave 4 and 5 (February-April 2023) and smoked in Wave 4. Cigarette quitting was defined as smoking at the prior wave and not smoking at follow-up. Cigarette reduction was defined as reducing daily cigarette consumption by ≥ 50% at follow-up. Rao-Scott Chi-Square tests and mixed-effects models were conducted.
results32.2% of participants (n = 128) reported not smoking at a subsequent wave. Fewer years of smoking cigarettes, fewer cigarettes smoked/day, lower cigarette dependence, and lower likelihood of using any additional tobacco product were significantly associated with quitting (p < 0.05); however, device type, wattage, nicotine concentration, nicotine formulation, and flavor were not significantly associated with quitting. Participants who used non-tobacco flavored ENDS and smoked more cigarettes/day were more likely to report smoking reduction at follow-up in bivariate analyses (p < 0.05), but not in adjusted models.
conclusionsAmong U.S. adults using ENDS ≥ 5 days/week alongside cigarette smoking, device and liquid characteristics were not associated with quitting behaviors or smoking reduction 6-12 months later in adjusted models. The study's limitations underscore the need for larger longitudinal and randomized studies tracking diverse ENDS characteristics, cigarette cessation, and reduction over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.